Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
J Epidemiol. 2011;21(6):401-16. doi: 10.2188/jea.je20100190. Epub 2011 Oct 22.
China has one of the highest carrier prevalences of hepatitis B virus (HBV) in the world: nearly 10% of the general population. The disease burden of HBV infection and hepatocellular carcinoma (HCC) is also believed to be among the world's largest, and that of hepatitis C virus (HCV) infection is likely to be substantial as well. However, the epidemiology and measures to control HBV and HCV infection in China remain relatively unknown outside the country. We review the epidemiology of HBV and HCV infection, the disease burden of and risk factors for HCC, and current control measures against HBV and HCV infection in China. We also discuss the relevant literature and implications for future studies of hepatitis and HCC in China.
中国是世界上乙型肝炎病毒 (HBV) 携带者流行率最高的国家之一：近 10%的一般人群。HBV 感染和肝细胞癌 (HCC) 的疾病负担也被认为是世界上最大的，丙型肝炎病毒 (HCV) 感染的疾病负担也可能很大。然而，HBV 和 HCV 感染在中国的流行病学和控制措施在国外仍然相对不为人知。我们回顾了中国 HBV 和 HCV 感染的流行病学、HCC 的疾病负担和危险因素，以及目前针对 HBV 和 HCV 感染的控制措施。我们还讨论了相关文献和对中国未来肝炎和 HCC 研究的影响。
